ADAR1 Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4M Buy
228,520
+193,128
+546% +$23.4M 1.12% 18
2026
Q1
$5.79M Buy
+35,392
New +$5.44M 0.34% 66
2025
Q2
Sell
-6,074
Closed -$463K 221
2025
Q1
$463K Sell
6,074
-15,900
-72% -$1.22M 0.09% 109
2024
Q4
$1.52M Buy
21,974
+18,340
+505% +$1.32M 0.3% 61
2024
Q3
$265K Sell
3,634
-38,583
-91% -$2.85M 0.04% 150
2024
Q2
$2.83M Buy
+42,217
New +$1.64M 0.53% 29

Other funds holding INSM

ADAR1 Capital Management's INSM Position: Q2 2026 in Review

ADAR1 Capital Management increased its Insmed (INSM) stake by 546% in Q2 2026, buying an estimated $23.4M and bringing the position to 228,520 shares worth $24.4M. The position accounts for 1.12% of the portfolio, ranked #18.

ADAR1 Capital Management first reported a position in INSM in Q2 2024 and has held it in 6 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • ADAR1 Capital Management held 228,520 shares of Insmed worth $24.4M as of Q2 2026.
  • ADAR1 Capital Management bought 193,128 Insmed shares in Q2 2026, an estimated $23.4M.
  • Insmed made up 1.12% of ADAR1 Capital Management's portfolio in Q2 2026, its #18 holding.
  • ADAR1 Capital Management first reported a position in Insmed in Q2 2024 and has held it in 6 quarters since.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.